Showing 6,136 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

PEP

What are the side effects of post-exposure prophylaxis (PEP)?

About HIV
November 2025
Sexually transmitted infections prevention

DoxyPEP Use Linked to Increased High-Level Tetracycline Resistance in Neisseria gonorrhoeae

Editor's pick
Contagion Live
26 November 2025
Resistance

New WHO framework aims to tackle rising resistance to HIV, STI, and hepatitis treatments

Editor's pick
CIDRAP
26 November 2025
Resistance

New Data Support Lenacapavir for Treatment-Experienced HIV

Editor's pick
Medscape (requires free registration)
26 November 2025
Treatment guidelines

Interview with Esteban Martinez: EACS Guideline Updates

Editor's pick
European Medical Journal
25 November 2025
New & experimental HIV treatments

Lenacapavir drug resistance in phase 1b study

Editor's pick
i-Base
25 November 2025
New & experimental HIV treatments

Merck's HIV combo matches Gilead's Biktarvy in latest phase 3 test for islatravir

Editor's pick
FierceBiotech
22 November 2025
Starting treatment

Non-AIDS Cancer Risk Drops Considerably When ART Is Initiated Within a Year of HIV Acquisition

Editor's pick
TheBodyPro
22 November 2025
Conception

Having a baby when you are living with HIV

About HIV
November 2025
New & experimental HIV treatments

Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filings

Editor's pick
FiercePharma
17 November 2025
Testing & health monitoring

Early HIV infection

About HIV
November 2025
Cardiovascular disease

Semaglutide Improves Cardiovascular Biomarkers in People With HIV

Editor's pick
POZ
13 November 2025
Antibody-based treatment

Antibody from Tanzanian woman suppresses almost all tested HIV variants including resistant viruses in pre-clinical study

News
10 November 2025
Weight gain & lipodystrophy

Less weight gain with Dovato than Biktarvy

News
3 November 2025
Drug interactions & pharmacokinetics

No Negative Impact for Individuals Taking Lenacapavir and Gender-Affirming Hormone Therapy

Editor's pick
Contagion Live
3 November 2025
Injectable & long-acting HIV treatment

Gilead ends phase 1 trial after settling on twice-yearly treatment partner for lenacapavir

Editor's pick
FierceBiotech
3 November 2025
New & experimental HIV treatments

IDWeek 2025: Pirmitegravir demonstrates proof of concept in HIV

Editor's pick
Clinical Trials Arena
30 October 2025
Treatment guidelines

New European HIV guidelines address sleep, obesity and breastfeeding

News
27 October 2025
Hepatitis B

Hepatitis B reactivation is rare after switching from tenofovir, two European studies show

News
24 October 2025
New & experimental HIV treatments

Weekly Oral HIV Treatment Looks Good at Two Years

Editor's pick
POZ
23 October 2025
Treatment guidelines

BHIVA publish 2025 interim update of ART guidelines for adults

Editor's pick
i-Base
22 October 2025
Resistance

Resistance following failure of injectable cabotegravir/rilpivirine may limit future treatment options

News
22 October 2025
Treatment guidelines

New guidance from ECDC and EACS aims to raise standards of HIV care, focusing on lifelong health

Editor's pick
European Centre for Disease Prevention and Control (ECDC)
21 October 2025
Injectable & long-acting HIV treatment

Are Cabotegravir Injections More Tolerable Than Lenacapavir?

Editor's pick
POZ
21 October 2025